Table 1.
Demographic data and diabetes-related complications of participants with active CN
| Acute CN | |
| Age, mean years±IC (S1) (A2) | 60.2±12.2 |
| Men, n (%) | 74 (71.8) |
| Body mass index (kg/m²), median (IQR) | 30.11 (25.74–33.14) |
| Missing data, n | 4 |
| Type of diabetes, n (%) | |
| Type 1 | 22 (21.6) |
| Type 2 | 77 (75.5) |
| Other | 3 (2.9) |
| Missing data, n | 1 |
| Diabetes duration, years, n (%) | |
| >20 | 41 (40.2) |
| 10–20 | 43 (42.2) |
| 5–10 | 10 (9.8) |
| <5 | 8 (7.8) |
| Missing data, n | 1 |
| Insulin use, n (%) | 69 (67.6) |
| Missing data, n | 1 |
| Microangiopathy, n (%) | 96 (94.1) |
| Missing data, n | 1 |
| Dialysis, n (%) | 4 (10.3) |
| Missing data, n | 64 |
| GFR (mL/min/1.73 m2), median (IQR) | 64 (46.5–90) |
| Missing data, n | 71 |
| Macroangiopathy, n (%) | 30 (31.3) |
| Missing data, n | 7 |
| DFU history (grade 3 IWGDF), n (%) | 63 (61.8) |
| Missing data, n | 1 |
CN, Charcot neuroarthropathy.